LL-37 vs Thymosin alpha-1
Where each stands with the FDA, how clinics sell it and what they charge, side by side. This compares what is published about them, not what they might do for you.
LL-37
Antimicrobial peptide (human cathelicidin)
- FDA standing
- No route for pharmacies to compound it
- Lowest monthly price
- $179.10/mo at FormBlends
- Clinics
- 4
- Sold as
- injection
- How it is given
- Subcutaneous injection
- Research in PubMed
- 17 clinical trials about it among 3,041 papers; 216 in animals only
Go to clinicLowest per monthLL-37 injection (10mg)
FormBlends · $179.10/mo
Thymosin alpha-1
Immune-modulating peptide
- FDA standing
- No route for pharmacies to compound it
- Lowest monthly price
- from $199/mo at Biotech Lifestyle
- Clinics
- 18
- Sold as
- injection, other
- How it is given
- Subcutaneous injection
- Research in PubMed
- 39 clinical trials about it among 632 papers; 185 in animals only
Go to clinicLowest per monthThymosin alpha-1 injection
Biotech Lifestyle · from $199/mo
Go to clinicLowest at a clinic we link toThymosin alpha-1 injection (5ml)
Pepti · $249/mo (≈ $267 per 30 days with its fees)
Clinics that sell both
Questions
Can pharmacies compound LL-37 and Thymosin alpha-1?
LL-37: No route for pharmacies to compound it. Thymosin alpha-1: No route for pharmacies to compound it. Each compound's page quotes the FDA's own words with the day we read them.
Which costs less, LL-37 or Thymosin alpha-1?
By the lowest price that compares per month: LL-37 from $179.10/mo at FormBlends, Thymosin alpha-1 from $199/mo at Biotech Lifestyle. Strengths and amounts differ between clinics, so compare what each price buys.
Which has been studied more in people, LL-37 or Thymosin alpha-1?
By PubMed's count of clinical trials about each (the compound in the title): LL-37, 17 clinical trials about it among 3,041 papers; 216 in animals only; Thymosin alpha-1, 39 clinical trials about it among 632 papers; 185 in animals only. Counted 16 November 2026. A count of trials says nothing about whether either works.